1 Min Read
April 21 (Reuters) - DIAMYD MEDICAL AB
* DIAMYD MEDICAL ENTERS AGREEMENT WITH GLOBAL CRO FOR THE DIAGNODE-2 TRIAL
* THE STUDY IS EXPECTED TO START IN AUTUMN 2017 Source text for Eikon:
Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.